Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015

J Gen Virol. 2016 Jul;97(7):1545-1550. doi: 10.1099/jgv.0.000484. Epub 2016 Apr 15.

Abstract

A natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus was isolated from an acute flaccid paralytic case in Brazil. Genome sequencing revealed the uncommon location of the crossover site in the VP1 coding region (nucleotides 3251-3258 of Sabin 3 genome). The Sabin 2 donor sequence replaced the last 118 nt of VP1, resulting in the substitution of the complete antigenic site IIIa by PV2-specific amino acids. The low overall number of nucleotide substitutions in P1 region indicated that the predicted replication time of the isolate was about 8-9 weeks. Two of the principal determinants of attenuation in Sabin 3 genomes were mutated (U472C and C2493U), but the temperature-sensitive phenotype of the isolate was preserved. Our results support the theory that there exists a PV3/PV2 recombination hotspot site in the tail region of the VP1 capsid protein and that the recombination may occur soon after oral poliovirus vaccine administration.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Brazil
  • Capsid / immunology
  • Capsid Proteins / genetics*
  • Capsid Proteins / immunology
  • Humans
  • Infant
  • Male
  • Poliomyelitis / virology*
  • Poliovirus / classification
  • Poliovirus / genetics*
  • Poliovirus / immunology
  • Poliovirus Vaccine, Oral / adverse effects*
  • Poliovirus Vaccine, Oral / immunology
  • Quadriplegia / virology*
  • Recombination, Genetic
  • Sequence Analysis, DNA
  • Vaccines, Synthetic / adverse effects*
  • Vaccines, Synthetic / immunology

Substances

  • Capsid Proteins
  • Poliovirus Vaccine, Oral
  • VP1 protein, Poliovirus
  • Vaccines, Synthetic